Clinical relevance of short-term glycemic variability in children and adolescents with type 1
diabetes: a narrative review - PMC Back to Top Skip to main content NIH NLM Logo Access keys …

Shortly after diagnosis of type 1 diabetes mellitus (T1DM) and initiation of insulin therapy,
many patients experience a transient partial remission (PR) phase, also known as the …

Context. Type 1 diabetes (T1D) is a heterogeneous disease affecting the islets and the
exocrine pancreas. How the topographical distribution of the involved tissue lesions …

Partial remission (PR) occurs in only half of people with new-onset type 1 diabetes (T1D)
and corresponds to a transient period characterized by low daily insulin needs, low glycemic …

Background: While insulin pumps remain the most common form of therapy for youths with
type 1 diabetes (T1DM), they differ in the extent to which they utilize data from continuous …

Abstract CD57+ CD8+ T cells, also referred as effector memory cells, are implicated in
various conditions including tumor immunity, virus immunity, and most recently with …

Aims To evaluate whether parameters of post-hypoglycemic hyperglycemia (PHH)
correlated with glucose homeostasis during the first year after type 1 diabetes onset and …

Background Considered a significant risk to health and survival, type 1 diabetes (T1D) is a
heterogeneous autoimmune disease characterized by hyperglycemia caused by an …

Aims. New‐onset type 1 diabetes mellitus (T1D) in pediatric patients represents a clinical
challenge for initial total daily insulin dosing (TIDD) due to substantial heterogeneity in …

Aims/hypothesis The aim of this work was to define a unique remission status using
glycaemia risk index (GRI) and other continuous glucose monitoring (CGM) metrics in …